Reducing Data on Breakthrough COVID Infections Not in Public Interest

Reducing Data on Breakthrough COVID Infections Not in Public Interest

Note that views expressed in this opinion article are the writer’s personal views and not necessarily those of TrialSite.

Joel S. Hirschhorn

Here is the critical question. How well does the artificial immunity provided by experimental COVID vaccines really work to protect people from getting infected? The answer is revealed by how many “breakthrough” infections develop two weeks or more after full vaccination. But can we trust the federal government to collect comprehensive data on them? Now, the answer is NO.

In early June, the CDC revealed that they stopped tracking all cases where experimental COVID vaccines failed to prevent infections. Rather than get systematic data on all breakthrough infections as it was doing originally, it announced that it would only attempt to get data on people who got very sick and were hospitalized or died.

The inadequacy of that is that the overwhelming number of American who have been infected have not gotten very sick or died. This means, therefore, that experimental COVID vaccines that are now seen only as having to be effective in preventing people from getting very sick or dying are not really necessar...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

Personal
$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
Professional
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee